Platelet-coupled IL-2 Cell therapy(Zcapsule)

N/A

Report date: 2024/02/18 20:00:30

Base Information

Drug NamePlatelet-coupled IL-2 Cell therapy(Zcapsule)
Drug Alias NameP-IL-2(Zcapsule)
ClassificationBiologics > Blood components
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsUrinary Bladder NeoplasmsSmall Cell Lung CarcinomaOvarian Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZcapsule Pharmaceuticals (Shaoxing) Co LtdZhejiang University
China Registration ClassN/A

Develop Information

Active CompaniesZcapsule Pharmaceuticals (Shaoxing) Co LtdZhejiang University
Inactive CompaniesN/A
Active IndicationsUrinary Bladder NeoplasmsSmall Cell Lung CarcinomaOvarian Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A